Evidence map›Paper›PMID 22090013›Full record

ReviewDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2011

[Lymphadenectomy for malignancies of the upper gastrointestinal tract].

C Schuhmacher, A Novotny, D Reim, K Ulm, H Friess

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Limitations of surgery for cancer of the upper gastrointestinal tract].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2014
    Review
  2. [Treatment of gastric cancer beyond current guideline: state of the art].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

C SchuhmacherChirurgische Klinik und Poliklinik Klinikum rechts der Isar, Technischen Universität München, Ismaningerstrasse 22, Munich, Germany. schuhmacher@chir.med.tu-muenchen.de
A Novotny
D Reim
K Ulm
H Friess

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies from specialized and high volume centers revealed an improved overall survival for patients subjected to extended lymphadenectomy. The drawbacks of radical lymph node dissection seem to be represented in higher rates of morbidity and mortality and thus are correlated to the surgical expertise of the respective institution. Especially patients in the early stages of metastatic lymph node spread benefit from extended and more radical lymphadenectomy. In a retrospective analysis of this institution's own patients, a pN0 category pT stage and the amount of retrieved lymph nodes have been found to be independent prognostic factors. In patients with up to six positive nodes (pN1) pT stage, the number of retrieved nodes, the number of positive nodes and R stage are correlated to survival prognosis. If more than six nodes are invaded only the amount of metastatic nodes and R stage are relevant prognostic factors. It will be of upmost interest to compare these data with analyses from regional and national cancer registers for gastric and esophageal cancer. As so far no reliable procedure for preoperative determination of lymphatic spread exists, the recommendations by the respective research organizations will have to be adopted until further notice, which is D2 lymphadenectomy for locally advanced gastric cancer and 2-field lymphadenectomy for patients with advanced esophageal cancer.Due to higher complication rates for patients subjected to radical lymphadenectomy, it is recommended that these procedures be performed in specialized high volume centers with corresponding surgical experience.

Indexed as

Clinical CompetenceDisease-Free SurvivalEsophageal NeoplasmsGermanyHumansLymphatic MetastasisLymph Node ExcisionNeoplasm StagingPostoperative ComplicationsPrognosisRegistriesStomach Neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.